Clinical Trials Browser

Anemia, Refractory, with Excess of Blasts, Lymphoma, Myeloproliferative Disorders, Leukemia, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

NCT04305691 2026-02-27

Trial of Ixazomib for Kaposi Sarcoma

Phase 2 Recruiting

41 enrolled

Sarcoma

Sarcoma, Kaposi

NCT06410209 2026-02-27

A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study

Phase 2 Recruiting

190 enrolled

Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

NCT06219317 2026-02-23

ICARS

Phase 2 Recruiting

136 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05504291 2026-02-17

A Study to Give Treatment Inside the Eye to Treat Retinoblastoma

Phase 2 Recruiting

26 enrolled

Other solid neoplasm

Retinoblastoma

NCT05718323 2026-02-06

RAISE

Phase 2 Recruiting

44 enrolled

Thoracic

SCLC,Extensive Stage

NCT05180097 2026-02-02

Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma

Phase 2 Recruiting

84 enrolled

Lymphoid

Hodgkin Disease

NCT05633615 2026-02-02

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Phase 2 Recruiting

396 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT05806515 2026-01-29

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

Phase 2 Recruiting

44 enrolled

Genitourinary

Prostatic Neoplasms

NCT05040360 2025-12-15

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

Phase 2 Recruiting

141 enrolled

Adenoma, Islet Cell

NCT04205968 2025-11-05

Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

Phase 2 Recruiting

94 enrolled

Metastatic Small Intestinal Adenocarcinoma

NCT05890352 2025-10-20

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

Phase 2 Recruiting

227 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT07209059 2025-10-06

FINISH-HL

Phase 2 Recruiting

30 enrolled

Lymphoid

Hodgkin Disease

NCT06326190 2025-09-16

LUMEN-1

Phase 2 Recruiting

136 enrolled

CNS

Meningioma

NCT04511013 2025-09-11

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Phase 2 Recruiting

112 enrolled

CNSDermatologic

Brain Neoplasms, Melanoma

NCT01766297 2025-09-09

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

Phase 2 Recruiting

132 enrolled

Breast

Breast Neoplasms

NCT02598349 2025-09-09

Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas

Phase 2 Recruiting

60 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT07130032 2025-08-19

reICB

Phase 2 Recruiting

90 enrolled

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

Clinical Trials

MMRC Horizon One: RRMM (MMRC-099)

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

GABLE

EMPIRE

Sonrotoclax Plus Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma Planned for Standard of Care CAR-T Cell Therapy

IPROC

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

Canbiome2

PALEO

Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Phase II Study of the Combination of Durvalumab (MEDI4736) (PDL1 Inhibitor) and Olaparib (PARP Inhibitor) in Advanced Cholangiocarcinoma After Initial Chemotherapy and Durvalumab (BIL-PPP)

Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALL

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

INSPIRE: INnovative SABR for Prostate Cancer All IREland

Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia

A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis

START-lung

Study for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab.

Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS Lymphoma

SLIDE-HCC

ISG-TULIPS

AsterA

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

CAPTUR

ISG-MCS

ISG-ARTICLE

ACCELERATE

Trial of Ixazomib for Kaposi Sarcoma

A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study

ICARS

A Study to Give Treatment Inside the Eye to Treat Retinoblastoma

RAISE

Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

FINISH-HL

LUMEN-1

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas

reICB